Scar border zone mass and presence of border zone channels assessed with cardiac magnetic resonance imaging are associated with ventricular arrhythmia in patients with ST-segment elevation myocardial infarction. Issue 3 (28th December 2022)

• Record Type: Journal Article
• Authors: Thomsen, Anna F; Bertelsen, Litten; Jøns, Christian; Jabbari, Reza; Lønborg, Jacob; Kyhl, Kasper; Göransson, Christoffer; Nepper-Christensen, Lars; Atharovski, Kiril; Ekström, Kathrine; Tilsted, Hans-Henrik; Pedersen, Frants; Køber, Lars; Engstrøm, Thomas; Vejlstrup, Niels; Jacobsen, Peter Karl
• Is Part Of: Europace. Volume 25:Issue 3(2023)
• Page Start: 978
• Page End: 988
• Publication Date: 2022-12-28
• Subjects: Cardiac magnetic resonance -- Late gadolinium enhancement -- Scar -- ST-segment elevation myocardial infarction -- Ventricular arrhythmia; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/euac256
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: Aims: Late gadolinium enhancement cardiac magnetic resonance (CMR) permits characterization of left ventricular ischaemic scars. We aimed to evaluate if scar core mass, border zone (BZ) mass, and BZ channels are risk markers for subsequent ventricular arrhythmia (VA) in ST-segment elevation myocardial infarction (STEMI). Methods and results: A sub-study of the DANish Acute Myocardial Infarction-3 multi-centre trial and Danegaptide phase II proof-of-concept clinical trial in which a total of 843 STEMI patients had a 3-month follow-up CMR. Of these, 21 patients subsequently experienced VA during 100 months of follow-up and were randomly matched 1:5 with 105 controls. A VA event was defined as: ventricular tachycardia, ventricular fibrillation, or sudden cardiac death. Ischaemic scar characteristics were automatically detected by specialized software. We included 126 patients with a median left ventricular ejection fraction of 51.0 ± 11.6% in cases with VA vs. 55.5 ± 8.5% in controls ( P = 0.10). Cases had a larger mean BZ mass and more often BZ channels compared to controls [BZ mass: 17.2 ± 10.3 g vs. 10.3 ± 6.0 g; P = 0.0002; BZ channels: 17 (80%) vs. 44 (42%); P = 0.001]. A combination of ≥17.2 g BZ mass and the presence of BZ channels was five times more prevalent in cases vs. controls ( P ≤ 0 .00001) with an odds ratio of 9.40 (95% confidence interval 3.26–27.13; P ≤ 0 .0001) for VA. This identified cases with 52% sensitivity and 90% specificity. Conclusion(s): Scar characterization with CMR indicates that a combination of ≥17.2 g BZ mass and the presence of BZ channels had the strongest association with subsequent VA in STEMI patients. ClinicalTrials.gov: Unique identifier: NCT01435408 (DANAMI 3-iPOST and DANAMI 3-DEFER), NCT01960933 (DANAMI 3-PRIMULTI), and NCT01977755 (Danegaptide). Graphical Abstract: Graphical Abstract Flowchart in the study population from ST-segment myocardial infarction to arrhythmic endpoint.